ArticlePharmaceutics2020

Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA.

Alvaro Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.